CELLIANT® is backed by science. It starts with our Science Advisory Board
that oversees the development and execution of the clinical research.

The FDA determined products containing CELLIANT® are medical devices
because they are intended to temporarily increase blood flow and local circulation
at the site of application in healthy individuals.

As part of the 513(g) submission process, the FDA reviewed and commented
on appropriate health and wellness claims for CELLIANT products.

The FDA has determined that CELLIANT® products
are medical devices as defined in section 201(h) of the
Federal Food, Drug and Cosmetic Act and are general wellness products.

The FDA has not approved or designated CELLIANT® products for
any purpose and has not made any determination about,
or endorsement of, its stated use or benefits.